SEATTLE, May 24, 2022--Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostic technology, today announced the addition of two senior executives, each of whom will play a pivotal role in guiding the company toward its goal of delivering the first FDA-cleared non-invasive glucose monitor. Steven Kent joins the company as Chief Product Officer and Peter Conley as Chief Financial Officer and SVP, Intellectual Property. They join Ron Erickson (Chairman), Phil Bosua (Chie
Phoenix, Arizona--(Newsfile Corp. - May 10, 2022) - The Stock Day Podcast welcomed Know Labs, Inc. (OTCQB: KNWN) ("the Company"), a company that is transforming non-invasive medical diagnostics. The company's proprietary technology, Bio-RFID™, uses radio frequency spectroscopy to capture the unique molecular signatures of analytes, such as glucose, in the bloodstream. Chairman of the Company, Ron Erickson, joined Stock Day host Everett Jolly. Jolly began the interview by asking about the Company
SEATTLE, April 05, 2022--Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced it has been granted two new foundational patents that add significant value to its IP portfolio and proprietary Bio-RFID™ technology. The two patents protect the ability to create and utilize any database built with data captured through non-invasive sensors. This widens the technological gap between Know Labs and others pursuing non-invasive diagnostics, while opening